By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today reported that its fourth-quarter revenues increased 10 percent year over year with growth across all segments aided by currency effects.

The Franklin Lakes, NJ-based maker of medical, research, and diagnostic products recorded total revenues of $2.05 billion for the fourth quarter ended Sept. 30, compared to revenues of $1.87 billion for Q4 2010. On a currency-neutral basis its revenues rose 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.